A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.
Clinical trial NCT03103724 · COMPLETED
Trial details
- NCT number
- NCT03103724
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2021-04-23
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.